These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35147657)

  • 1. Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    Tan SHX; Pung R; Wang LF; Lye DC; Ong B; Cook AR; Tan KB
    JAMA; 2022 Mar; 327(12):1181-1182. PubMed ID: 35147657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    Burckhardt RM; Dennehy JJ; Poon LLM; Saif LJ; Enquist LW
    J Virol; 2022 Feb; 96(3):e0197321. PubMed ID: 34817198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    Abbasi J
    JAMA; 2022 Jan; 327(2):115. PubMed ID: 35015054
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.
    Mayr FB; Talisa VB; Shaikh O; Yende S; Butt AA
    N Engl J Med; 2022 Apr; 386(14):1375-1377. PubMed ID: 35139265
    [No Abstract]   [Full Text] [Related]  

  • 5. Israel's high case plateau may offer worrisome portent.
    Wadman M
    Science; 2021 Sep; 373(6562):1428-1429. PubMed ID: 34554791
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A
    BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audio Interview: Covid-19 as an Endemic Disease.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2022 Feb; 386(6):e21. PubMed ID: 35139281
    [No Abstract]   [Full Text] [Related]  

  • 9. Scientists see a 'really, really tough winter' with Omicron.
    Kupferschmidt K
    Science; 2021 Dec; 374(6574):1421-1422. PubMed ID: 34914506
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 vaccine boosters: The time to act is now.
    Petersen M; Schwab J; Havlir DV
    PLoS Med; 2021 Dec; 18(12):e1003882. PubMed ID: 34882675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Oct; 385(17):e72. PubMed ID: 34670050
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?
    Sarpatwari A; Pandya A; Hyle EP; Persad G
    Ann Intern Med; 2022 Feb; 175(2):280-282. PubMed ID: 34748375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 boosters in rich nations will delay vaccines for all.
    Chagla Z; Pai M
    Nat Med; 2021 Oct; 27(10):1659-1660. PubMed ID: 34465921
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
    Accorsi EK; Britton A; Shang N; Fleming-Dutra KE; Link-Gelles R; Smith ZR; Derado G; Miller J; Schrag SJ; Verani JR
    N Engl J Med; 2022 Jun; 386(25):2433-2435. PubMed ID: 35613039
    [No Abstract]   [Full Text] [Related]  

  • 16. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
    Rababa'h AM; Abedalqader NN; Ababneh M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China's zero-COVID strategy: what happens next?
    Mallapaty S
    Nature; 2022 Feb; 602(7895):15-16. PubMed ID: 35087249
    [No Abstract]   [Full Text] [Related]  

  • 18. Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    Larkin HD
    JAMA; 2022 Jul; 328(3):234. PubMed ID: 35852521
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
    Muhsen K; Maimon N; Mizrahi A; Varticovschi B; Bodenheimer O; Gelbshtein U; Grotto I; Cohen D; Dagan R
    N Engl J Med; 2022 Jan; 386(4):399-401. PubMed ID: 34936758
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.